Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

1.

Death and cardiovascular events after bacteriuria among adult women with chronic kidney disease.

Dhanyamraju S, Foltzer MA, Tang X, Kirchner HL, Perkins RM.

Int J Nephrol Renovasc Dis. 2012;5:143-50. doi: 10.2147/IJNRD.S37061. Epub 2012 Nov 8.

PMID:
23204852
[PubMed]
Free PMC Article
2.

Bisphosphonate therapy, death, and cardiovascular events among female patients with CKD: a retrospective cohort study.

Hartle JE, Tang X, Kirchner HL, Bucaloiu ID, Sartorius JA, Pogrebnaya ZV, Akers GA, Carnero GE, Perkins RM.

Am J Kidney Dis. 2012 May;59(5):636-44. doi: 10.1053/j.ajkd.2011.11.037. Epub 2012 Jan 14.

PMID:
22244796
[PubMed - indexed for MEDLINE]
3.

Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG.

Circulation. 2006 Jun 13;113(23):2713-23. Epub 2006 Jun 5.

PMID:
16754803
[PubMed - indexed for MEDLINE]
Free Article
4.

Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.

Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, Fluck N, MacLeod A, McNamee P, Prescott G, Smith C.

Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210. Review.

PMID:
20441712
[PubMed - indexed for MEDLINE]
Free Article
5.

Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation Trial.

Zoungas S, Lui M, Kerr PG, Teede HJ, McNeil JJ, McGrath BP, Polkinghorne KR.

Intern Med J. 2011 Dec;41(12):825-32. doi: 10.1111/j.1445-5994.2010.02226.x. Epub 2010 Mar 18.

PMID:
20298505
[PubMed - indexed for MEDLINE]
6.

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

J Am Soc Nephrol. 2004 May;15(5):1307-15.

PMID:
15100371
[PubMed - indexed for MEDLINE]
Free Article
7.

Urinary sodium and potassium excretion and risk of cardiovascular events.

O'Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, McQueen M, Sleight P, Sharma AM, Dans A, Probstfield J, Schmieder RE.

JAMA. 2011 Nov 23;306(20):2229-38. doi: 10.1001/jama.2011.1729.

PMID:
22110105
[PubMed - indexed for MEDLINE]
8.

Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.

Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, Worchel J.

Drug Saf. 2006;29(7):621-32.

PMID:
16808554
[PubMed - indexed for MEDLINE]
9.

Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.

Degli Esposti L, Saragoni S, Batacchi P, Benemei S, Geppetti P, Sturani A, Buda S, Degli Esposti E.

Clin Ther. 2012 Jan;34(1):190-9. doi: 10.1016/j.clinthera.2011.12.011.

PMID:
22284998
[PubMed - indexed for MEDLINE]
10.

Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.

Meisinger C, Döring A, Löwel H; KORA Study Group.

Eur Heart J. 2006 May;27(10):1245-50. Epub 2006 Apr 12.

PMID:
16611670
[PubMed - indexed for MEDLINE]
Free Article
11.

Statin therapy and risks for death and hospitalization in chronic heart failure.

Go AS, Lee WY, Yang J, Lo JC, Gurwitz JH.

JAMA. 2006 Nov 1;296(17):2105-11.

PMID:
17077375
[PubMed - indexed for MEDLINE]
12.

Increased risk of stroke in patients with chronic kidney disease after recurrent hypoglycemia.

Yu TM, Lin CL, Chang SN, Sung FC, Kao CH.

Neurology. 2014 Aug 19;83(8):686-94. doi: 10.1212/WNL.0000000000000711. Epub 2014 Jul 16.

PMID:
25031280
[PubMed - in process]
13.

Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.

Lipscombe LL, Gomes T, Lévesque LE, Hux JE, Juurlink DN, Alter DA.

JAMA. 2007 Dec 12;298(22):2634-43.

PMID:
18073359
[PubMed - indexed for MEDLINE]
14.

Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study.

Glynn LG, Reddan D, Newell J, Hinde J, Buckley B, Murphy AW.

Nephrol Dial Transplant. 2007 Sep;22(9):2586-94. Epub 2007 Apr 23.

PMID:
17452408
[PubMed - indexed for MEDLINE]
Free Article
15.

Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease.

Chen SC, Chang JM, Liu WC, Huang JC, Tsai JC, Lin MY, Su HM, Hwang SJ, Chen HC.

Nephrol Dial Transplant. 2012 Mar;27(3):1064-70. doi: 10.1093/ndt/gfr407. Epub 2011 Aug 3.

PMID:
21813825
[PubMed - indexed for MEDLINE]
Free Article
16.

Bisphosphonates and mortality in women with CKD and the presence or absence of cardiovascular disease.

Perkins RM, Kirchner HL, Matsushita K, Bucaloiu ID, Norfolk E, Hartle JE.

Clin J Am Soc Nephrol. 2014 May;9(5):874-80. doi: 10.2215/CJN.07790713. Epub 2014 Feb 27.

PMID:
24578337
[PubMed - in process]
17.

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Hallé JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S; HOPE Study Investigators.

JAMA. 2001 Jul 25;286(4):421-6.

PMID:
11466120
[PubMed - indexed for MEDLINE]
18.

Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.

McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, Chen SC, Norris KC, McFarlane S, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti J, Whaley-Connell AT, Brenner RM, Bakris GL; KEEP Investigators.

Am Heart J. 2008 Aug;156(2):277-83. doi: 10.1016/j.ahj.2008.02.024. Epub 2008 Jun 4. Erratum in: Am Heart J. 2008 Dec;156(6):1132. Vassaloti, Joseph [corrected to Vassalotti, Joseph].

PMID:
18657657
[PubMed - indexed for MEDLINE]
19.

Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.

Wali RK, Iyengar M, Beck GJ, Chartyan DM, Chonchol M, Lukas MA, Cooper C, Himmelfarb J, Weir MR, Berl T, Henrich WL, Cheung AK.

Circ Heart Fail. 2011 Jan;4(1):18-26. doi: 10.1161/CIRCHEARTFAILURE.109.932558. Epub 2010 Oct 29.

PMID:
21036889
[PubMed - indexed for MEDLINE]
Free Article
20.

Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.

Roumie CL, Choma NN, Kaltenbach L, Mitchel EF Jr, Arbogast PG, Griffin MR.

Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1053-63. doi: 10.1002/pds.1820.

PMID:
19637402
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk